Workflow
Osisko Development Strengthens Technical Team With Appointment of Vice President, Exploration
Globenewswire· 2025-11-03 20:30
MONTREAL, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or the "Company") is pleased to announce the appointment of Mr. Scott Smith as Vice President, Exploration effective November 1, 2025. Mr. Smith joins from Prime Mining Corp. where he most recently served as Executive Vice President, Exploration until its acquisition by Torex Gold Resources Inc. in October 2025. "We are delighted to bolster our exploration team with Scott's appointment. He bring ...
Digi Power X Strengthens Balance Sheet to Support 2026 AI Infrastructure Development Plan
Globenewswire· 2025-11-03 20:30
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. MIAMI, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), an innovative energy infrastructure company, today announced a significant strengthening of its balance sheet and liquidity position to support its 2026 AI infrastructure development and is also ple ...
Willis Lease Finance Corporation Announces New Revolving Credit Facility for Joint Venture, Willis Mitsui & Co. Engine Support Limited
Globenewswire· 2025-11-03 20:25
COCONUT CREEK, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ: WLFC) (“WLFC” or the “Company”), the leading lessor of commercial aircraft engines and a global provider of aviation services, today announced that on October 31, 2025, Willis Mitsui & Co. Engine Support Limited (“WMES”), the Company’s long-standing joint venture with Mitsui & Co., Ltd. (“Mitsui”), entered into a new $750.0 million, five-year, revolving credit facility (“Credit Agreement”). Proceeds from the rev ...
Bombardier Announces Notice of Redemption for All of its 7.875% Senior Notes due 2027
Globenewswire· 2025-11-03 20:25
MONTREAL, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier”) today announced that it has issued a notice of redemption for all of its outstanding 7.875% Senior Notes due 2027, in an aggregate principal amount of US$99,431,000 (the “2027 Notes”). As set forth in the notice of redemption issued today in respect of the 2027 Notes, the redemption date is December 3, 2025, and the redemption price for the 2027 Notes is 100% of the principal amount redeemed, plus accrued and unpaid interest. On Nov ...
Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301
Globenewswire· 2025-11-03 20:10
临床试验结果 - 公司公布BB-301 1b/2a期临床试验的积极中期结果 所有6名Cohort 1患者均达到正式统计学应答标准 应答率为100% [1] - 患者在接受BB-301治疗后表现出显著且持续的改善 包括吞咽困难症状负担减轻 吞咽后残留物积累减少 饮用固定体积液体所需时间缩短 以及吞咽时咽部闭合改善 [1] - 具体改善数据为:悉尼吞咽问卷得分下降328点 液体咽部最大收缩面积减少40% 所有稠度食物咽部最大收缩面积减少42% 液体总咽部残留减少45% 所有稠度食物总咽部残留减少49% 液体标准化残留比率量表得分下降69% 所有稠度食物标准化残留比率量表得分下降63% [6] 监管进展与公司计划 - 基于积极的中期数据 美国FDA已授予BB-301用于治疗伴有吞咽困难的眼咽肌营养不良症的快速通道资格 该疗法此前已获得FDA和欧洲药品管理局的孤儿药资格认定 [1][4] - 2025年第四季度 Cohort 2的首位患者已成功接受BB-301治疗 公司计划在2026年与FDA会面 以确认BB-301的关键研究设计 [4] - 公司任命曾担任Intra-Cellular Therapies Inc董事长、首席执行官兼联合创始人的Sharon Mates博士为董事会成员 [4] 产品与平台技术 - BB-301是一种基于公司专有“沉默与替换”DNA导向RNA干扰平台的新型基因疗法 其机制是沉默致病的突变型PABPN1基因表达 同时提供功能性的替代蛋白 [8][9] - 该疗法针对影响97%眼咽肌营养不良症患者的进行性吞咽困难这一严重威胁生命的并发症 [2]
Cipher Mining Provides Third Quarter 2025 Business Update
Globenewswire· 2025-11-03 20:10
核心观点 - 公司2025年第三季度实现营收7170万美元,非GAAP调整后收益为4100万美元 [1] - 公司与亚马逊网络服务签署了为期15年、价值约55亿美元的数据中心园区租约,以支持AI工作负载 [2] - 公司获得西德克萨斯州1吉瓦站点合资项目的大约95%所有权,以开发名为Colchis的站点 [3][9] 财务业绩 - 2025年第三季度营收为7170万美元,比特币挖矿收入为7170万美元 [1][21] - 2025年第三季度净亏损为300万美元,或每股0.01美元 [9] - 2025年第三季度非GAAP调整后收益为4100万美元,或每股摊薄收益0.10美元 [1][9][24] - 截至2025年9月30日,现金及现金等价物为12.074亿美元,总资产为28.409亿美元 [18][19] - 成功完成13亿美元的可转换票据发行 [9] 业务运营与战略发展 - 执行与亚马逊网络服务的15年数据中心园区租约,提供300兆瓦容量,预计2026年7月开始分两阶段交付,8月开始收取租金 [2] - AI托管合同代表约85亿美元的租赁付款 [9] - 站点管道容量为3.2吉瓦 [9] - 公司专注于为比特币挖矿和HPC托管开发和运营工业规模的数据中心 [10] 合资项目与基础设施 - 成立合资实体开发西德克萨斯州1吉瓦站点Colchis,公司预计提供大部分资金,获得约95%股权 [3][9] - Colchis站点包括与美国电力公司完全执行的1吉瓦直连协议,目标在2028年通电 [4] - 该620英亩土地毗邻现有变电站,具备开发HPC数据中心的所有必要特征 [4] 行业趋势与公司定位 - 行业迅速演变,验证了一级超大规模企业将转向公司及德克萨斯州非传统区域的论点 [5] - 公司相信其是全球范围内最有优势抓住日益增长的电力短缺所创造额外机会的企业之一 [5] - 公司目标是成为市场领导者,包括在比特币挖矿增长、数据中心建设以及作为全球最大HPC公司的托管合作伙伴方面进行创新 [10]
Kraig Biocraft Laboratories Confirms Spider Silk Production Operations Unaffected by Southeast Asia Typhoons due to Strategic Relocations to Highland Over Last 24 Months
Globenewswire· 2025-11-03 20:05
ANN ARBOR, Mich., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that its production operations in Vietnam remain fully secure and uninterrupted following the recent series of typhoons that have impacted parts of Southeast Asia. Kraig Labs confirmed that its spider silk production facilities and infrastructure sustained no damage or disruption, including its mulberry feedstock supplies, ...
Vertex Announces Third Quarter 2025 Financial Results and $150 Million Class A Common Stock Repurchase Program
Globenewswire· 2025-11-03 20:05
核心观点 - 公司公布2025年第三季度财务业绩,实现两位数收入增长和强劲盈利能力,并宣布首次股票回购计划 [1][2] 第三季度财务业绩 - 总收入为1.92112亿美元,同比增长12.7% [5] - 软件订阅收入为1.64824亿美元,同比增长12.7% [5] - 云收入为9200万美元,同比增长29.6% [5] - 年度经常性收入(ARR)为6.482亿美元,同比增长12.4% [5] - 运营收入为430万美元,低于去年同期的490万美元 [5] - 非GAAP运营收入为3710万美元,高于去年同期的3340万美元 [5] - 净收入为400万美元,低于去年同期的720万美元 [5] - 调整后税息折旧及摊销前利润(Adjusted EBITDA)为4349.3万美元,高于去年同期的3862.3万美元 [5] - 调整后税息折旧及摊销前利润率为22.6%,与去年同期的22.7%基本持平 [5] 关键业务指标 - 截至2025年9月30日,每位直接客户的平均年收入(AARPC)为133,484美元,高于去年同期的118,800美元 [5] - 净收入留存率(NRR)为107%,低于去年同期的111% [5] - 总收入留存率(GRR)为95%,与去年同期持平 [5] - 直接客户数量为4,856个,间接客户数量为516个,总客户数量为5,372个 [21] 管理层评论与展望 - 首席执行官David DeStefano表示,云迁移和全球税制日益复杂化将继续推动对公司解决方案的强劲需求 [2] - Christopher Young将于本月接任总裁兼首席执行官,其拥有领导大型科技公司及在微软推动人工智能发展的经验 [2] - 第四季度收入指引为1.92亿美元至1.96亿美元,调整后税息折旧及摊销前利润指引为4000万美元至4200万美元 [6] - 全年收入指引为7.457亿美元至7.497亿美元,云收入增长指引为28%,调整后税息折旧及摊销前利润指引上调至1.591亿美元至1.611亿美元 [6][7] 资本分配与股票回购 - 董事会授权一项股票回购计划,允许公司回购最多1.5亿美元的A类普通股 [8] - 回购计划没有终止日期,可根据市场情况通过公开市场或私下协商交易等方式进行 [8][9] 非GAAP财务指标 - 非GAAP毛利率为73.9%,与去年同期的74.0%基本持平 [39] - 非GAAP净收入为2858.2万美元,非GAAP稀释每股收益为0.17美元 [39] - 自由现金流为3015.2万美元,自由现金流利润率为15.7%,高于去年同期的10.8% [39]
Unicycive Therapeutics to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference
Globenewswire· 2025-11-03 20:05
LOS ALTOS, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced that Shalabh Gupta, M.D., Chief Executive Officer, will participate in a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference on Monday, November 10, 2025, at 3:30 p.m. ET. A link to the live and archived webcast may be accessed on the Unicycive webs ...
OHA Leads Private Financing Supporting FleetPride’s Merger with TruckPro
Globenewswire· 2025-11-03 20:00
New York, New York, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Oak Hill Advisors (“OHA”) served as Administrative Agent and Lead Left Arranger for a private unitranche financing supporting the recapitalization and merger of FleetPride, Inc. (“FleetPride”) with TruckPro, LLC (“TruckPro”), the two largest distributors of aftermarket parts for heavy-duty trucks in the United States. FleetPride is a portfolio company of American Securities. OHA is the largest holder of the newly raised debt facility, reinforcing its lo ...